Painter, G. R., Almond, M. R., Trost, L. C., Lampert, B. M., Neyts, J., De Clercq, E., . . . Hostetler, K. Y. (2007). Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]- Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections. American Society for Microbiology.
Chicago Style citaatPainter, George R., et al. Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]- Adenine, CMX157, As a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections. American Society for Microbiology, 2007.
MLA citatiePainter, George R., et al. Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]- Adenine, CMX157, As a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections. American Society for Microbiology, 2007.